Severity and Therapeutic Decisions Based on Lesion Location in Patients With Hidradenitis Suppurativa
International Journal of Dermatology · 2025-09 · 64 (9) · 1607-1614
DOI: 10.1111/ijd.17861 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, online erschienen am 20.05.2025. Verfasst von Daniel Muñoz-Barba und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Virgen de Las Nieves University Hospital, Granada, Spain. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Clinical Decision-Making. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background
Hidradenitis suppurativa (HS) is a chronic inflammatory disease for which several phenotypic classifications have been proposed in recent years to optimize medical care. The aim of this study was to define a new classification of HS based on the anatomical distribution of lesions, serving as a tool for therapeutic decision‐making.
Methods
This cross‐sectional study with consecutive sampling included patients attending their first medical consultation at the Hidradenitis Suppurativa Unit of Virgen de las Nieves University Hospital in Granada, Spain, between January 1, 2017, and March 1, 2024. Patients were classified into four groups based on the anatomical distribution of HS: Upper, Atypical, Lower, and Progressor HS. Sociodemographic variables, personal history, and HS‐related variables were collected.
Results
A total of 557 patients were included, with a similar proportion of men and women. Patients with the Upper type exhibited milder forms of HS and underwent surgical treatment more frequently. In contrast, those with the Progressor type presented more severe forms of HS and required more immunomodulatory treatment. Patients in the Atypical and Lower groups showed more heterogeneity in therapeutic approaches, although the presence of lesions in specific locations may help predict the need for early initiation of more aggressive treatments.
Conclusions
We propose a new HS classification based on the location of lesions. This classification can be used alone or in conjunction with previous ones to identify patients at higher risk of progression and to guide therapeutic decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Department, Virgen de Las Nieves University Hospital, Granada, Spain.
- Instituto de Investigación Biosanitaria, Granada, Spain.
- Dermatology Department, School of Medicine, University of Granada, Granada, Spain.
ORCID-Profile: Daniel Muñoz-Barba, Sofía Haselgruber de Francisco, Carlos Cuenca-Barrales, Manuel Sánchez-Díaz, Alejandro Molina-Leyva
Zitieren
APA
Muñoz-Barba, D., Haselgruber de Francisco, S., León-Pérez, F. J., Cuenca-Barrales, C., Arias-Santiago, S., Sánchez-Díaz, M., & Molina-Leyva, A. (2025). Severity and Therapeutic Decisions Based on Lesion Location in Patients With Hidradenitis Suppurativa. International Journal of Dermatology, 64(9), 1607-1614. https://doi.org/10.1111/ijd.17861
Vancouver
Muñoz-Barba D, Haselgruber de Francisco S, León-Pérez FJ, Cuenca-Barrales C, Arias-Santiago S, Sánchez-Díaz M, et al. Severity and Therapeutic Decisions Based on Lesion Location in Patients With Hidradenitis Suppurativa. International Journal of Dermatology. 2025;64(9):1607-1614. doi:10.1111/ijd.17861
BibTeX
@article{MuozBarba2025,
author = {Muñoz-Barba, Daniel and Haselgruber de Francisco, Sofía and León-Pérez, Francisco Javier and Cuenca-Barrales, Carlos and Arias-Santiago, Salvador and Sánchez-Díaz, Manuel and Molina-Leyva, Alejandro},
title = {Severity and Therapeutic Decisions Based on Lesion Location in Patients With Hidradenitis Suppurativa},
journal = {International Journal of Dermatology},
year = {2025},
volume = {64},
number = {9},
pages = {1607--1614},
doi = {10.1111/ijd.17861}
}
EUVIMED